AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca total revenue ($M) ($M)
Form 6-K Quarterly & Form 20-F Revenue by Stream & Region Tables
Latest, FY2025
58,739
Period ended Dec 31, 2025
Change on a year earlier
+8.6%
54,073 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 58,739 | +8.6% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 54,073 | +18.0% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 45,811 | +3.3% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 44,351 | +18.5% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 37,417 | +40.6% | Form 6-K FY2021Q4 Earnings Release ↗ |
| FY2020 | Dec 31, 2020 | 26,617 | +9.2% | Form 6-K FY2020Q4 Earnings Release ↗ |
| FY2019 | Dec 31, 2019 | 24,384 | +10.4% | Form 20-F (filed 2020-03-03) ↗ |
| FY2018 | Dec 31, 2018 | 22,090 | -1.7% | Form 20-F (filed 2019-03-05) ↗ |
| FY2017 | Dec 31, 2017 | 22,465 | -2.3% | Form 20-F (filed 2018-03-06) ↗ |
| FY2016 | Dec 31, 2016 | 23,002 | -6.9% | Form 20-F (filed 2018-03-06) ↗ |
| FY2015 | Dec 31, 2015 | 24,708 | – | Form 20-F (filed 2018-03-06) ↗ |
Breakdown
What makes up total revenue ($m)
- Product sales ($M)55,573 · FY2025
- Alliance revenue ($M)3,067 · FY2025
- Collaboration revenue ($M)99 · FY2025
- United States (US) — Total revenue ($M)25,450 · FY2025
- Emerging Markets — Total revenue ($M)15,303 · FY2025
- Europe — Total revenue ($M)12,739 · FY2025
- Established Rest of World (Japan, Canada, Australia & New Zealand) — Total revenue ($M)5,247 · FY2025
Cite this data
StockData. (2026). AstraZeneca Total revenue ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/rev_total_disagg
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.